ID   p53NiS1
AC   CVCL_8902
SY   P53NiS1
DR   CLO; CLO_0008338
DR   ATCC; CRL-2619
DR   Wikidata; Q54937308
RX   PubMed=11984000;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Unexplicit; Deletion in exon 5; Zygosity=Hemizygous (PubMed=11984000).
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Misspelling: P53N1S1; Note=Occasionally.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
CC   Breed/subspecies: C57BL/6 Trp53+/-.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
RX   PubMed=11984000; PMCID=PMC2039931;
RA   Govindarajan B., Klafter R., Miller M.S., Mansur C.P., Mizesko M.,
RA   Bai X.-H., LaMontagne K.R. Jr., Arbiser J.L.;
RT   "Reactive oxygen-induced carcinogenesis causes hypermethylation of
RT   p16(Ink4a) and activation of MAP kinase.";
RL   Mol. Med. 8:1-8(2002).
//